216 related articles for article (PubMed ID: 1378466)
1. Mechanism of Helicobacter pylori pathogenesis: focus on mucus.
Slomiany BL; Slomiany A
J Clin Gastroenterol; 1992; 14 Suppl 1():S114-21. PubMed ID: 1378466
[TBL] [Abstract][Full Text] [Related]
2. Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data.
Slomiany BL; Piotrowski J; Slomiany A
Arzneimittelforschung; 1997 Apr; 47(4A):475-82. PubMed ID: 9205747
[TBL] [Abstract][Full Text] [Related]
3. Mucus and H. pylori.
Allen A; Newton J; Oliver L; Jordan N; Strugala V; Pearson JP; Dettmar PW
J Physiol Pharmacol; 1997 Sep; 48(3):297-305. PubMed ID: 9376612
[TBL] [Abstract][Full Text] [Related]
4. Role of mucus in gastric mucosal protection.
Slomiany BL; Slomiany A
J Physiol Pharmacol; 1991 Jun; 42(2):147-61. PubMed ID: 1782415
[TBL] [Abstract][Full Text] [Related]
5. Morphological aspects of the cytotoxic action of Helicobacter pylori.
Taniguchi Y; Ido K; Kimura K; Satoh K; Yoshida Y; Takimoto T; Kihira K; Ookawara S; Mato M
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S17-21. PubMed ID: 7537615
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Helicobacter pylori glycosulfatase activity toward gastric sulfomucin by nitecapone.
Murty VL; Piotrowski J; Morita M; Slomiany A; Slomiany BL
Biochem Int; 1992 May; 26(6):1091-9. PubMed ID: 1632804
[TBL] [Abstract][Full Text] [Related]
7. Glycosulfatase activity of H. pylori toward human gastric mucin: effect of sucralfate.
Slomiany BL; Murty VL; Piotrowski J; Grabska M; Slomiany A
Am J Gastroenterol; 1992 Sep; 87(9):1132-7. PubMed ID: 1381553
[TBL] [Abstract][Full Text] [Related]
8. Sucralfate counteracts the inhibition of gastric mucosal mucin receptor by Helicobacter pylori lipopolysaccharide.
Slomiany A; Piotrowski J; Slomiany BL
Scand J Gastroenterol Suppl; 1995; 210():77-81. PubMed ID: 8578214
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide a virulence factor of Helicobacter pylori: effect of antiulcer agents.
Piotrowski J
J Physiol Pharmacol; 1998 Mar; 49(1):3-24. PubMed ID: 9594407
[TBL] [Abstract][Full Text] [Related]
10. Effects of cagA+ and cagA- strains of Helicobacter pylori on the human gastric mucus layer thickness.
Al-Marhoon MS; Nunn S; Soames RW
J Gastroenterol Hepatol; 2005 Aug; 20(8):1246-52. PubMed ID: 16048574
[TBL] [Abstract][Full Text] [Related]
11. Gastroprotective agents in mucosal defense against Helicobacter pylori.
Slomiany BL; Murty VL; Piotrowski J; Slomiany A
Gen Pharmacol; 1994 Sep; 25(5):833-41. PubMed ID: 7835626
[TBL] [Abstract][Full Text] [Related]
12. Glycosulfatase activity of Helicobacter pylori towards gastric sulfomucin: effect of nitecapone.
Slomiany BL; Murty VL; Piotrowski J; Morita M; Slomiany A
J Physiol Pharmacol; 1993 Mar; 44(1):7-16. PubMed ID: 8518427
[TBL] [Abstract][Full Text] [Related]
13. Effects of pH on Helicobacter pylori binding to human gastric mucins: identification of binding to non-MUC5AC mucins.
Lindén S; Mahdavi J; Hedenbro J; Borén T; Carlstedt I
Biochem J; 2004 Dec; 384(Pt 2):263-70. PubMed ID: 15260802
[TBL] [Abstract][Full Text] [Related]
14. Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis.
McGuckin MA; Every AL; Skene CD; Linden SK; Chionh YT; Swierczak A; McAuley J; Harbour S; Kaparakis M; Ferrero R; Sutton P
Gastroenterology; 2007 Oct; 133(4):1210-8. PubMed ID: 17919495
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Helicobacter pylori colonization by an antiulcer agent, sulglycotide.
Czajkowski A; Piotrowski J; Yotsumoto F; Slomiany A; Slomiany BL
Biochem Mol Biol Int; 1993 Apr; 29(5):965-71. PubMed ID: 8508147
[TBL] [Abstract][Full Text] [Related]
16. Mucolytic effects of Helicobacter pylori.
Sarosiek J; Peura DA; Guerrant RL; Marshall BJ; Laszewicz W; Gabryelewicz A; McCallum RW
Scand J Gastroenterol Suppl; 1991; 187():47-55. PubMed ID: 1775924
[TBL] [Abstract][Full Text] [Related]
17. Sulglycotide effect on the proteolytic and lipolytic activities of Helicobacter pylori toward gastric mucus.
Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A; Slomiany BL
Am J Gastroenterol; 1994 Feb; 89(2):232-6. PubMed ID: 8304309
[TBL] [Abstract][Full Text] [Related]
18. The microbiology and epidemiology of Helicobacter pylori infection.
Lee A
Scand J Gastroenterol Suppl; 1994; 201():2-6. PubMed ID: 8047819
[TBL] [Abstract][Full Text] [Related]
19. Long-standing gastric mucosal barrier dysfunction in Helicobacter pylori-induced gastritis in mongolian gerbils.
Sun YQ; Söderholm JD; Petersson F; Borch K
Helicobacter; 2004 Jun; 9(3):217-27. PubMed ID: 15165257
[TBL] [Abstract][Full Text] [Related]
20. Increase in apoptosis and decrease in ornithine decarboxylase activity of the gastric mucosa in patients with atrophic gastritis and gastric ulcer after successful eradication of Helicobacter pylori.
Hirasawa R; Tatsuta M; Iishi H; Yano H; Baba M; Uedo N; Sakai N
Am J Gastroenterol; 1999 Sep; 94(9):2398-402. PubMed ID: 10483998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
